Your browser doesn't support javascript.
loading
Current status of artificial intelligence methods for skin cancer survival analysis: a scoping review.
Schreidah, Celine M; Gordon, Emily R; Adeuyan, Oluwaseyi; Chen, Caroline; Lapolla, Brigit A; Kent, Joshua A; Reynolds, George Bingham; Fahmy, Lauren M; Weng, Chunhua; Tatonetti, Nicholas P; Chase, Herbert S; Pe'er, Itsik; Geskin, Larisa J.
Afiliación
  • Schreidah CM; Vagelos College of Physicians and Surgeons, Columbia University, New York, NY, United States.
  • Gordon ER; Vagelos College of Physicians and Surgeons, Columbia University, New York, NY, United States.
  • Adeuyan O; Vagelos College of Physicians and Surgeons, Columbia University, New York, NY, United States.
  • Chen C; Vagelos College of Physicians and Surgeons, Columbia University, New York, NY, United States.
  • Lapolla BA; Department of Dermatology, Columbia University Irving Medical Center, New York, NY, United States.
  • Kent JA; Jacobs School of Medicine and Biomedical Sciences, University at Buffalo, Buffalo, NY, United States.
  • Reynolds GB; The Data Science Institute, Columbia University, New York, NY, United States.
  • Fahmy LM; Vagelos College of Physicians and Surgeons, Columbia University, New York, NY, United States.
  • Weng C; The Data Science Institute, Columbia University, New York, NY, United States.
  • Tatonetti NP; Department of Biomedical Informatics, Columbia University, New York, NY, United States.
  • Chase HS; The Data Science Institute, Columbia University, New York, NY, United States.
  • Pe'er I; Department of Biomedical Informatics, Columbia University, New York, NY, United States.
  • Geskin LJ; Department of Computational Biomedicine, Cedars-Sinai Medical Center, Los Angeles, CA, United States.
Front Med (Lausanne) ; 11: 1243659, 2024.
Article en En | MEDLINE | ID: mdl-38711781
ABSTRACT
Skin cancer mortality rates continue to rise, and survival analysis is increasingly needed to understand who is at risk and what interventions improve outcomes. However, current statistical methods are limited by inability to synthesize multiple data types, such as patient genetics, clinical history, demographics, and pathology and reveal significant multimodal relationships through predictive algorithms. Advances in computing power and data science enabled the rise of artificial intelligence (AI), which synthesizes vast amounts of data and applies algorithms that enable personalized diagnostic approaches. Here, we analyze AI methods used in skin cancer survival analysis, focusing on supervised learning, unsupervised learning, deep learning, and natural language processing. We illustrate strengths and weaknesses of these approaches with examples. Our PubMed search yielded 14 publications meeting inclusion criteria for this scoping review. Most publications focused on melanoma, particularly histopathologic interpretation with deep learning. Such concentration on a single type of skin cancer amid increasing focus on deep learning highlight growing areas for innovation; however, it also demonstrates opportunity for additional analysis that addresses other types of cutaneous malignancies and expands the scope of prognostication to combine both genetic, histopathologic, and clinical data. Moreover, researchers may leverage multiple AI methods for enhanced benefit in analyses. Expanding AI to this arena may enable improved survival analysis, targeted treatments, and outcomes.
Palabras clave

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Idioma: En Revista: Front Med (Lausanne) Año: 2024 Tipo del documento: Article País de afiliación: Estados Unidos

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Idioma: En Revista: Front Med (Lausanne) Año: 2024 Tipo del documento: Article País de afiliación: Estados Unidos